Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams Buys 3,968,253 Shares of Stock

Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams acquired 3,968,253 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The stock was acquired at an average cost of $1.26 per share, with a total value of $4,999,998.78. Following the completion of the acquisition, the director now owns 4,695,861 shares in the company, valued at $5,916,784.86. This trade represents a 500.00 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Vivani Medical Price Performance

Shares of NASDAQ:VANI opened at $1.39 on Thursday. Vivani Medical, Inc. has a one year low of $0.84 and a one year high of $7.80. The firm has a market capitalization of $76.81 million, a price-to-earnings ratio of -2.96 and a beta of 3.20. The company’s fifty day moving average price is $1.22 and its 200-day moving average price is $1.36.

Vivani Medical (NASDAQ:VANI) last released its quarterly earnings results on Tuesday, August 13th. The company reported ($0.10) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.02.

Wall Street Analyst Weigh In

Separately, HC Wainwright initiated coverage on Vivani Medical in a report on Thursday, November 7th. They issued a “buy” rating and a $3.00 price target for the company.

About Vivani Medical

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.